triple-hormone-receptor agonist retatrutide for obesity triple hormone receptor A review of an investigational drug retatrutide, a novel agent the treatment of Original Article: Triple–Hormone-Receptor Agonist Retatrutide

doi: 10.1007/s11011-017-0059-4 125 Diz-ChavesYTobaLFandioJGonzlez-MatasLCGarcia-SeguraLMMalloF

While initial Phase 2 data demonstrated distinct metabolic effects from this concurrent activation [3], Retatrutide has since advanced into Phase 3 clinical evaluations including the TRIUMPH clinical program to further characterize its triple-agonist profile

PLOS ONE

Each vial contains a combination of high-purity Retatrutide formulated under stringent quality control standards to ensure stability, precision, and consistency in controlled experimental research

When prescribed off-label for weight loss, patients often cover out-of-pocket costs

How does Sofwave drive long-term retention in aesthetic practices